Crispr Therapeutics shares owned by Nuveen Asset Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Nuveen Asset Management
from 13F filings
Historical chart of Nuveen Asset Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Nuveen Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Nuveen Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.0M | 22k | 46.98 |
| 2024-06-30 | $1.2M | 23k | 54.01 |
| 2024-03-31 | $2.0M | 30k | 68.16 |
| 2023-09-30 | $1.8M | 39k | 45.39 |
| 2023-06-30 | $2.1M | 38k | 56.14 |
| 2021-09-30 | $16M | 139k | 111.93 |
| 2021-06-30 | $21M | 132k | 161.89 |
| 2021-03-31 | $13M | 107k | 121.84 |
| 2020-12-31 | $5.2M | 34k | 153.12 |
| 2020-09-30 | $5.4M | 65k | 83.66 |
| 2020-06-30 | $1.4M | 20k | 73.51 |
| 2020-03-31 | $1.0M | 24k | 42.39 |
| 2019-12-31 | $1.9M | 32k | 60.90 |
| 2019-09-30 | $1.3M | 32k | 41.00 |